VIP - Vascular Infection Project
Cohorte VIP
1 other identifier
observational
1,000
1 country
1
Brief Summary
Constitution of a prospective multicentric observational database to study vascular infections, both native, especially aortitis, and vascular graft and endograft infections. Clinical and paraclinical data on medical, surgical, anesthetic and intensive care management will be collected in order to better characterize these infections
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2022
CompletedFirst Submitted
Initial submission to the registry
June 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 10, 2032
March 10, 2025
March 1, 2025
10 years
June 4, 2024
March 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mortality
mortality r
Year 1
Secondary Outcomes (4)
mortality
Day 30, Year 2, Year 5
morbidity
Year 1
relapse
year 1, Year 2, Year 5
reinfection
year 1, Year 2, Year 5
Study Arms (2)
Native vascular infection
Prosthetic vascular infections
Eligibility Criteria
ents with a vascular infection, either native (aortitis, arteritis) or prosthetic (vascular graft, endograft and/or stent)
You may qualify if:
- ≥ 18 years-old;
- all patients with a vascular infection, either native (aortitis, arteritis) or prosthetic (vascular graft, endograft and/or stent),
- oral consent
You may not qualify if:
- patient under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Bordeaux
Bordeaux, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2024
First Posted
March 10, 2025
Study Start
May 10, 2022
Primary Completion (Estimated)
May 10, 2032
Study Completion (Estimated)
May 10, 2032
Last Updated
March 10, 2025
Record last verified: 2025-03